Palexia (Tapentadol Hydrochloride)

Tapentadol hydrochloride, the active ingredient in Palexia, is an opioid analgesic presented as a strength/form for oral use. It is indicated for the management of moderate to severe pain in adult patients when other analgesics are insufficient. GNH USA supplies Palexia as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Palexia as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Tapentadol is an opioid analgesic that acts on the central nervous system to relieve pain. It is used in the following clinical situations:

- Acute postoperative pain: Provides effective analgesia after surgical procedures. - Chronic musculoskeletal pain: Helps  manage  chronic  muscle  and  skeletal  pain  when  conventional  treatments  are  inadequate. - Cancer  or  oncologic  pain  in  patients  who  require  strong  opio  ‑